August 2009
Nasal corticosteroids
As of June 1, prior authorization is required for all brand-name nasal corticosteroids.
Generic flunisolide (Nasarel®, Nasalide®) and fluticasone (Flonase®) have proven track records and are available without prior authorization to treat allergy symptoms. These generics can reduce patients' copayments for nasal corticosteroids.
If flunisolide or fluticasone are ineffective or not tolerated, the following brand-name medications may be covered after prior authorization:
- Nasacort AQ® may be covered at the preferred/formulary copayment.
- More costly brand-name nasal corticosteroids, including Nasonex®, Omnaris®, Patanase®, Rhinocort Aqua® and Veramyst®, provide no additional clinical value. They will be covered at the non-preferred/non-formulary copayment.
Regence's medication policy encourages the use of generics, including flunisolide and fluticasone.
Prior authorization (PDF) is required for new prescriptions only. Due to significant cost savings, we encourage you to consider prescribing generic flunisolide or fluticasone for patients currently using brand-name nasal corticosteroids.
If you have any questions, please contact Pharmacy Customer Service at 1 (800) 572-0316.